RAMOT at Tel Aviv University Ltd.

Biomarkers for risk assessment in colorectal cancer patients

Posted by RAMOT at Tel Aviv University Ltd.Responsive · Innovative Products and Technologies · Israel

Summary of the technology

Mortalin/GRP75, a ubiquitous mitochondrial chaperone related to the cytosolic heat shock protein 70 (HSP70), was quantified for the first time in sera of colorectal cancer patients. The significance of mortalin in blood to the survival prospects of colorectal cancer patients was demonstrated, concurrence with documented extracellular soluble HSP70 (sHSP70).
Circulating Mortalin and extracellular soluble HSP70 (sHSP70) are independent risk factors for short survival of the patients. Moreover, concurrence of high circulating HSP70 and mortalin levels adds a high prognostic value to the TNM stage (TNM Classification of Malignant Tumors) and will identify colorectal cancer patients at high risk of poor survival.

Project ID : 5-2012-401

Technology
We have developed an ELISA-based immunoassay that measures the levels of two proteins in the blood, Mortalin/GRP75 and HSP70, identifying colorectal cancer patients at high risk of poor survival.
Mortalin/GRP75, is a ubiquitous mitochondrial chaperone related to the cytosolic heat shock protein 70 (HSP70). We have conducted a clinical trial, collecting and analyzing blood samples from 175 colorectal cancer patients. We demonstrated, for the first time, the presence of circulating mortalin in blood of cancer patients. We have found that circulating Mortalin and extracellular soluble HSP70 (sHSP70) are independent risk factors for poor survival of the patients. Taken together, analysis of these two biomarkers provides a highly significant prognostic value to identify colorectal cancer patients at high risk of poor survival.
Experiment highlights:

  • Cox regression analysis indicated that high mortalin (>60ng/ml) is a risk factor for poor survival.
  • Serum levels of sHSP70 and mortalin in patients were independent variables.
  • Concurrence of high sHSP70 and mortalin was associated with rapid disease progression (HR=4, 2.04-8.45, P

Project manager

Adi Elkeles
BD Manager

Project researchers

Zvi Fishelson
T.A.U Tel Aviv University, Medicine-Sackler Faculty
Cell and Developmental Biology

Prohaszka Zoltan
,

Related keywords

  • Medicine, Human Health
  • Medical Technology / Biomedical Engineering
  • Biology / Biotechnology
  • Cellular and Molecular Biology Technology
  • Microbiology Technology
  • Bioinformatics Technology
  • Micro- and Nanotechnology related to Biological sciences
  • Microbiology Market
  • Micro- and Nanotechnology related to Biological sciences
  • Biochemistry / Biophysics Market
  • Stem cells and biobanks
  • Cellular and Molecular Biology Market
  • Bioinformatics Market
  • Diagnostic
  • Therapeutic
  • Clinical Medicine
  • Pharmaceutical Indications
  • Oncology / Cancer
  • Life Sciences and Biotechnology
  • Biomarkers

About RAMOT at Tel Aviv University Ltd.

Technology Transfer Office from Israel

Ramot is Tel Aviv University's (TAU) technology transfer company and its liaison to industry, bringing promising scientific discoveries made at

Send your request

By clicking "Send your request" you are signing up and accepting our Terms of Service and Privacy policy

Technology Offers on Innoget are directly posted and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.